TRXO — Columbine Valley Resources Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2013 March 31st | R2014 March 31st | 2015 March 31st | 2016 March 31st | 2017 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0.547 | 1.18 |
Cost of Revenue | |||||
Gross Profit | — | 0 | -0.03 | 0.048 | 0.287 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.612 | 0.013 | 11 | 16.2 | 4.93 |
Operating Profit | -0.612 | -0.013 | -11 | -15.7 | -3.74 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.215 | -0.013 | -11 | -15.7 | -4.25 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.215 | -0.013 | -11 | -15.7 | -4.25 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.215 | -0.013 | -11 | -15.7 | -4.25 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.215 | -0.013 | -11 | -15.8 | -4.31 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.44 | -0.275 | -7.74 | -2.58 | -1.36 |
Dividends per Share |